JP2006515992A - ヒト骨粗鬆症遺伝子 - Google Patents

ヒト骨粗鬆症遺伝子 Download PDF

Info

Publication number
JP2006515992A
JP2006515992A JP2006500965A JP2006500965A JP2006515992A JP 2006515992 A JP2006515992 A JP 2006515992A JP 2006500965 A JP2006500965 A JP 2006500965A JP 2006500965 A JP2006500965 A JP 2006500965A JP 2006515992 A JP2006515992 A JP 2006515992A
Authority
JP
Japan
Prior art keywords
bmp2
polypeptide
nucleic acid
osteoporosis
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006500965A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006515992A5 (fr
Inventor
スティルカースドッター，ウンナー
ヨハンスドッター，ヴァラ，ドゥロフン
グルシャー，ジェフリー，アール．
Original Assignee
デコード ジェネティクス イーエッチエフ．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/346,723 external-priority patent/US20030176344A1/en
Application filed by デコード ジェネティクス イーエッチエフ． filed Critical デコード ジェネティクス イーエッチエフ．
Priority claimed from PCT/US2004/000990 external-priority patent/WO2004065938A2/fr
Publication of JP2006515992A publication Critical patent/JP2006515992A/ja
Publication of JP2006515992A5 publication Critical patent/JP2006515992A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2006500965A 2003-01-16 2004-01-15 ヒト骨粗鬆症遺伝子 Pending JP2006515992A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/346,723 US20030176344A1 (en) 2000-09-14 2003-01-16 Human osteoporosis gene
PCT/US2004/000990 WO2004065938A2 (fr) 2000-09-14 2004-01-15 Gene humain de l'osteoporose

Publications (2)

Publication Number Publication Date
JP2006515992A true JP2006515992A (ja) 2006-06-15
JP2006515992A5 JP2006515992A5 (fr) 2007-03-01

Family

ID=35034737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500965A Pending JP2006515992A (ja) 2003-01-16 2004-01-15 ヒト骨粗鬆症遺伝子

Country Status (3)

Country Link
EP (1) EP1585837A2 (fr)
JP (1) JP2006515992A (fr)
CA (1) CA2512239A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022871A2 (fr) * 2000-09-14 2002-03-21 Decode Genetics Ehf Gene humain de l'osteoporose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022871A2 (fr) * 2000-09-14 2002-03-21 Decode Genetics Ehf Gene humain de l'osteoporose

Also Published As

Publication number Publication date
EP1585837A2 (fr) 2005-10-19
CA2512239A1 (fr) 2004-08-05

Similar Documents

Publication Publication Date Title
US20030054531A1 (en) Human stroke gene
US20050164220A1 (en) Susceptibility gene for human stroke: method of treatment
JP2004508835A (ja) ヒト骨粗鬆症遺伝子
US20020045577A1 (en) Human schizophrenia gene
CA2502359A1 (fr) Gene de susceptibilite d'un infarctus du myocarde
CA2502357A1 (fr) Gene de susceptibilite pour l'infarctus du myocarde, et procedes de traitement
AU2003201728B2 (en) Gene for peripheral arterial occlusive disease
US20020094954A1 (en) Human schizophrenia gene
WO2003076658A2 (fr) Gene de predisposition a la maladie de parkinson idiopathique a apparition tardive
AU2003201728A1 (en) Gene for peripheral arterial occlusive disease
US20060141462A1 (en) Human type II diabetes gene-slit-3 located on chromosome 5q35
US7507531B2 (en) Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
US20040014099A1 (en) Susceptibility gene for human stroke; methods of treatment
JP2006515992A (ja) ヒト骨粗鬆症遺伝子
WO2003000735A2 (fr) Acides nucleiques codant pour des recepteurs olfactifs
WO2004065938A2 (fr) Gene humain de l'osteoporose
US20040142440A1 (en) Seryl transfer RNA synthetase polynucleotides and polypeptides and methods of use thereof
US20030176344A1 (en) Human osteoporosis gene
WO2003040393A2 (fr) Acides nucleiques codant des proteases
WO2003062469A2 (fr) Gene lie a l'arthrose
WO2003002606A2 (fr) Acides nucleiques codant des canaux ioniques
WO2003002741A2 (fr) Acides nucleiques codant pour des recepteurs nucleaires
WO2003040392A2 (fr) Acides nucleiques codant des enzymes d'une biosynthese d'acide gras a tres longue chaine
WO2001029266A2 (fr) Identification des mutations de l'ataxie recessive spastique autosomiale de charlevoix-saguenay (arsacs) et methodes d'utilisation correspondantes
WO1999021996A1 (fr) Procedes et compositions servant a diagnostiquer et a traiter des cataractes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091210

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100519